One-year survival following early revascularization for cardiogenic shock

J S Hochman1, L A Sleeper, H D White

  • 1St Luke's-Roosevelt Hospital Center, 1111 Amsterdam Ave, New York, NY 10025, USA.

JAMA
|February 15, 2001
PubMed

Insights

Early revascularization significantly improves 1-year survival for acute myocardial infarction patients with cardiogenic shock. This intervention is particularly beneficial for those under 75 years old.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) is the primary cause of mortality in patients hospitalized with acute myocardial infarction (AMI).
  • Effective management strategies for AMI-induced CS are crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the impact of early revascularization (ERV) on 1-year survival rates in patients experiencing AMI complicated by CS.
  • To compare the efficacy of ERV versus initial medical stabilization (IMS) in this high-risk patient population.

Main Methods:

  • The study involved 302 patients with AMI and CS, randomly assigned to either an ERV group or an IMS group.
  • The ERV group underwent revascularization within 6 hours, while the IMS group received medical stabilization with delayed revascularization in some cases.
  • Outcomes assessed included all-cause mortality and functional status at 1 year.

Main Results:

  • One-year survival was significantly higher in the ERV group (46.7%) compared to the IMS group (33.6%).
  • A notable treatment benefit was observed in patients younger than 75 years.
  • The majority of 1-year survivors in both groups were in New York Heart Association functional class I or II.

Conclusions:

  • Early revascularization improves 1-year survival for patients with AMI complicated by CS.
  • Rapid transfer to centers capable of early angiography and revascularization is recommended for these patients, especially those under 75.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K